T1D RELAY Study - Ages 8-17
Are you the parent of a child 8 - 17 that is newly diagnosed with type 1 diabetes? Your child may be eligible for a research study to see if the use of two drugs-rituximab-pvvr followed by abatacept will help to preserve remaining insulin in people with newly diagnosed diabetes. Participation involves 21 visits over 4 years. Compensation is provided.